Genetic Testing Market - Top Companies and Manufacturers

  • Report ID: 4745
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Companies Dominating the Genetic Testing Landscape

    • Genentech Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Sorenson Genomics
    • Abbott Molecular
    • Bayer AG
    • Biocartis
    • BioHelix
    • Quest Diagnostics
    • Exact Sciences Corporation
    • HTG Molecular Diagnostics, Inc.
    • PacBio

Browse Key Market Insights with Data Illustration:

In the News

  • Quest Diagnostics, announced the acquisition of Blueprint Genetics in an all-cash equity deal. Using proprietary algorithms and next-generation sequencing (NGS), Blueprint Genetics is a top provider of specialized genetic testing. It has extensive experience interpreting gene variants. In order to improve patient care and pharmaceutical medication research and development, Quest and Blueprint Genetics was estimated to provide access to practical insights into genetic and uncommon diseases. The deal's financial specifics weren't made public.
  • Exact Sciences Corporation declared that it had acquired PreventionGenetics, a genetic testing facility, in order to expand its portfolio of advanced cancer diagnostics and assist its entry into hereditary cancer testing (HCT). In order to speed up the availability of HCT and assisted more individuals in understanding their germline risk of developing cancer and other diseases, PreventionGenetics offers the clinical lab, experience, and fundamental technologies required.

Author Credits:  Radhika Pawar


  • Report ID: 4745
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of genetic testing is estimated at USD 24.43 billion.

The genetic testing market size was over USD 22.74 billion in 2024 and is projected to cross USD 72.05 billion by the end of 2037, witnessing more than 9.2% CAGR during the forecast period i.e., between 2025-2037. Rising prevalence of hereditary illnesses and the growing popularity of personalized medicine will boost the market growth.

Asia Pacific industry is predicted to account for the largest share of 36% by 2037, impelled by growing healthcare sector in the region.

The major players in the market include Genentech Inc., Sorenson Genomics, Abbott Molecular, Bayer AG, Biocartis, BioHelix, Quest Diagnostics, Exact Sciences Corporation, HTG Molecular Diagnostics, Inc., PacBio.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample